Evidence map›Paper›PMID 39005070›Full record

ArticleGenetics2024

Chk2 homolog Mek1 limits exonuclease 1-dependent DNA end resection during meiotic recombination in Saccharomyces cerevisiae.

Jennifer T Krystosek, Douglas K Bishop

Abstract read
In one paragraph

Article in Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jennifer T KrystosekDepartment of Radiation and Cellular Oncology/Department of Molecular Genetics and Cell Biology, University of Chicago, 920 E 58th Street, CLSC 817, Chicago, IL 60637, USA.ORCID 0009-0000-8330-5886
Douglas K BishopDepartment of Radiation and Cellular Oncology/Department of Molecular Genetics and Cell Biology, University of Chicago, 920 E 58th Street, CLSC 817, Chicago, IL 60637, USA.ORCID 0000-0001-5061-8085

Funding

Mechanism of Dmc1-mediated Meiotic Recombination in Budding YeastR35GM134942 · NIGMS · UNIVERSITY OF CHICAGO · PI BISHOP, DOUGLAS K · 2020 to 2024
$2.3M
NIGMS NIH HHS R35 GM134942NIH HHS # R35GM134942
6 · The paper itself

Abstract

The conserved Rad2/XPG family 5'-3' exonuclease, exonuclease 1 (Exo1), plays many roles in DNA metabolism including during resolution of DNA double-strand breaks via homologous recombination. Prior studies provided evidence that the end resection activity of Exo1 is downregulated in yeast and mammals by Cdk1/2 family cyclin-dependent and checkpoint kinases, including budding yeast kinase Rad53 which functions in mitotic cells. Here, we provide evidence that the master meiotic kinase Mek1, a paralog of Rad53, limits 5'-3' single-strand resection at the sites of programmed meiotic DNA breaks. Mutational analysis suggests that the mechanism of Exo1 suppression by Mek1 differs from that of Rad53.

Indexed as

Checkpoint Kinase 2DNA Breaks, Double-StrandedExodeoxyribonucleasesMAP Kinase Kinase 1MeiosisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell Cycle ProteinsHomologous RecombinationRecombination, GeneticCell Cycle ProteinsCheckpoint Kinase 2exodeoxyribonuclease IExodeoxyribonucleasesMAP Kinase Kinase 1RAD53 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsChk2DNA end resectionExo1meiosisMek1recombination

Identifiers

PMID39005070
PMCPMC11373520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.